| Trait Information | |
| Identifier | MONDO_0005173 |
| Description | A precancerous lesion of the skin composed of atypical keratinocytes. It is characterized by the presence of thick, scaly patches of skin. Several histologic variants have been described, including atrophic, acantholytic, and hyperkeratotic variants. [NCIT: P378] | Trait categories |
Cancer
Other disease
|
| Synonyms |
4 synonyms
|
| Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
|---|---|---|---|---|---|---|
| PGS020001 (AK_PRS_SBayesRC) |
PGP000859 | Parasuraman A et al. Am J Transplant (2026) |
Actinic keratosis | actinic keratosis | 6,794,567 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS020001/ScoringFiles/PGS020001.txt.gz |
|
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|---|
| PPM038281 | PGS020001 (AK_PRS_SBayesRC) |
PSS013904| European Ancestry| 12,843 individuals |
PGP000859 | Parasuraman A et al. Am J Transplant (2026) |
Reported Trait: Actinic keratosis | OR: 2.38 [2.27, 2.5] | — | — | age, sex, 10 PCs | OR per SD increase in PRS; P = 116x10-269 |
| PPM038282 | PGS020001 (AK_PRS_SBayesRC) |
PSS013904| European Ancestry| 12,843 individuals |
PGP000859 | Parasuraman A et al. Am J Transplant (2026) |
Reported Trait: >=20 actinic keratosis lesions | OR: 5.06 [4.69, 5.46] | — | — | age, sex, 10 PCs | OR per SD increase in PRS, from multinomial logistic regression of AK burden (>20 vs 6-20 vs 1-5 vs none); P = 698x10-235 |
| PPM038283 | PGS020001 (AK_PRS_SBayesRC) |
PSS013904| European Ancestry| 12,843 individuals |
PGP000859 | Parasuraman A et al. Am J Transplant (2026) |
Reported Trait: >=20 actinic keratosis lesions (prediction) - simple clinical model | — | AUROC: 0.9 | — | age, sex, 10 PCs | AUC with PRS = 090 vs AUC without PRS (age, sex, 10PCs only) = 077; 13% AUC improvement; P = 750x10-114 |
| PPM038284 | PGS020001 (AK_PRS_SBayesRC) |
PSS013904| European Ancestry| 12,843 individuals |
PGP000859 | Parasuraman A et al. Am J Transplant (2026) |
Reported Trait: >=20 actinic keratosis lesions (prediction) - comprehensive clinical model | — | AUROC: 0.92 | — | age, sex, 10 PCs, sunburn history, hair colour, sun exposure, skin colour | AUC with PRS = 092 vs AUC without PRS = 086; 6% AUC improvement; P = 815x10-58 |
| PPM038285 | PGS020001 (AK_PRS_SBayesRC) |
PSS013905| European Ancestry| 203 individuals |
PGP000859 | Parasuraman A et al. Am J Transplant (2026) |
Reported Trait: Actinic keratosis in solid organ transplant recipients | OR: 1.79 [1.1, 2.91] | AUROC: 0.8 | — | age (at transplant), sex, 10 PCs, type of transplant | OR per SD increase in PRS; P = 197x10-2 Sensitivity analysis adjusting for type of immunosuppression: OR per SD = 175 (95% CI 107-286, P = 0025) Second sensitivity analysis adjusting for cumulative immunosuppression over time (mono/double/triple therapy): OR per SD = 175 (95% CI 107-286, P = 0025) - consistent with main estimate |
| PPM038286 | PGS020001 (AK_PRS_SBayesRC) |
PSS013906| European Ancestry| 963 individuals |
PGP000859 | Parasuraman A et al. Am J Transplant (2026) |
Reported Trait: Actinic keratosis (any AK, yes/no) in solid organ transplant recipients | OR: 2.49 [1.91, 3.23] | AUROC: 0.76 | — | age, sex, 10 PCs, type of transplant | OR per SD increase in PRS; P = 925x10-12 Sensitivity analysis including transplant type as covariate: OR per SD = 272 (95% CI 194-382, P = 668x10-9) |
| PPM038287 | PGS020001 (AK_PRS_SBayesRC) |
PSS013903| European Ancestry| 1,826 individuals |
PGP000859 | Parasuraman A et al. Am J Transplant (2026) |
Reported Trait: Actinic keratosis (any AK, yes/no) in solid organ transplant recipients | OR: 1.52 [1.3, 1.7] | AUROC: 0.73 | — | age, sex, 10 PCs, type of transplant | OR per SD increase in PRS; P = 357x10-12 |
| PPM038288 | PGS020001 (AK_PRS_SBayesRC) |
PSS013903| European Ancestry| 1,826 individuals |
PGP000859 | Parasuraman A et al. Am J Transplant (2026) |
Reported Trait: >20 actinic keratosis lesions (vs none) in solid organ transplant recipients | OR: 1.99 [1.51, 2.61] | AUROC: 0.82 | — | age, sex, 10 PCs, type of transplant | OR per SD increase in PRS, from multinomial logistic regression of AK burden; P = 896x10-7 |
| PPM038289 | PGS020001 (AK_PRS_SBayesRC) |
PSS013903| European Ancestry| 1,826 individuals |
PGP000859 | Parasuraman A et al. Am J Transplant (2026) |
Reported Trait: 6-20 actinic keratosis lesions (vs none) in solid organ transplant recipients | OR: 1.7 [1.41, 2.05] | AUROC: 0.78 | — | age, sex, 10 PCs, type of transplant | OR per SD increase in PRS; P = 250x10-8 |
| PPM038290 | PGS020001 (AK_PRS_SBayesRC) |
PSS013903| European Ancestry| 1,826 individuals |
PGP000859 | Parasuraman A et al. Am J Transplant (2026) |
Reported Trait: 1-5 actinic keratosis lesions (vs none) in solid organ transplant recipients | OR: 1.36 [1.18, 1.67] | AUROC: 0.82 | — | age, sex, 10 PCs, type of transplant | OR per SD increase in PRS; P = 239x10-5 |
| PPM038291 | PGS020001 (AK_PRS_SBayesRC) |
PSS013903| European Ancestry| 1,826 individuals |
PGP000859 | Parasuraman A et al. Am J Transplant (2026) |
Reported Trait: Actinic keratosis in lung transplant recipients | OR: 2.31 [1.58, 3.4] | — | — | age, sex, 10 PCs | OR per SD increase in PRS, subgroup by organ type; P = 190x10-5 |
| PPM038292 | PGS020001 (AK_PRS_SBayesRC) |
PSS013903| European Ancestry| 1,826 individuals |
PGP000859 | Parasuraman A et al. Am J Transplant (2026) |
Reported Trait: Actinic keratosis in heart transplant recipients | OR: 1.64 [1.28, 2.09] | — | — | age, sex, 10 PCs | OR per SD increase in PRS, subgroup by organ type; P = 684x10-5 |
| PPM038293 | PGS020001 (AK_PRS_SBayesRC) |
PSS013903| European Ancestry| 1,826 individuals |
PGP000859 | Parasuraman A et al. Am J Transplant (2026) |
Reported Trait: Actinic keratosis in liver transplant recipients | OR: 1.46 [1.08, 1.96] | — | — | age, sex, 10 PCs | OR per SD increase in PRS, subgroup by organ type; P = 136x10-2 |
| PPM038294 | PGS020001 (AK_PRS_SBayesRC) |
PSS013903| European Ancestry| 1,826 individuals |
PGP000859 | Parasuraman A et al. Am J Transplant (2026) |
Reported Trait: Actinic keratosis in kidney transplant recipients | OR: 1.37 [1.15, 1.63] | — | — | age, sex, 10 PCs | OR per SD increase in PRS, subgroup by organ type; P = 512x10-4 |
| PPM038295 | PGS020001 (AK_PRS_SBayesRC) |
PSS013903| European Ancestry| 1,826 individuals |
PGP000859 | Parasuraman A et al. Am J Transplant (2026) |
Reported Trait: AK-specific chemoprevention/field-therapy use (5-FU, imiquimod, or 3% diclofenac sodium) in solid organ transplant recipients | OR: 1.57 [1.36, 1.8] | — | — | age, sex, 10 PCs, type of transplant | OR per SD increase in PRS; P = 232x10-10 |
| PPM038296 | PGS020001 (AK_PRS_SBayesRC) |
PSS013903| European Ancestry| 1,826 individuals |
PGP000859 | Parasuraman A et al. Am J Transplant (2026) |
Reported Trait: 5-fluorouracil use in solid organ transplant recipients | OR: 1.61 [1.38, 1.88] | AUROC: 0.73 | — | age, sex, 10 PCs, type of transplant | OR per SD increase in PRS; P = 890x10-10 |
| PPM038297 | PGS020001 (AK_PRS_SBayesRC) |
PSS013903| European Ancestry| 1,826 individuals |
PGP000859 | Parasuraman A et al. Am J Transplant (2026) |
Reported Trait: Imiquimod use in solid organ transplant recipients | OR: 1.64 [1.28, 2.09] | — | — | age, sex, 10 PCs, type of transplant | OR per SD increase in PRS; P = 726x10-05 |
| PPM038298 | PGS020001 (AK_PRS_SBayesRC) |
PSS013903| European Ancestry| 1,826 individuals |
PGP000859 | Parasuraman A et al. Am J Transplant (2026) |
Reported Trait: Any chemoprevention use (AK-specific agents plus nicotinamide, capecitabine, acitretin) in solid organ transplant recipients | OR: 1.45 [1.29, 1.64] | — | — | age, sex, 10 PCs, type of transplant | OR per SD increase in PRS; P = 203x10-9 |
|
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| PSS013905 | Actinic keratosis; via dermatologist examination | — | [ ,
63.0 % Male samples |
Mean = 41.1 years Sd = 13.25 years |
European | — | STAR | Solid organ transplant recipients (Skin Tumors in Allograft Recipients Study) |
| PSS013906 | ICD 10 L570 | — | [ ,
72.0 % Male samples |
Mean = 69.9 years Sd = 7.6 years |
European | — | UKB | Solid organ transplant recipients from UK Biobank (distinct sub-population from the UKB GWAS discovery sample, which excluded SOTRs). |
| PSS013903 | SNOMED CODES 138825, 4299672, 42709860, 4304266 | — | [ ,
60.0 % Male samples |
Mean = 65.0 years Sd = 13.4 years |
European | — | AllofUs | Solid organ transplant recipients from All of Us (distinct sub-population from the AoU GWAS discovery sample, which excluded SOTRs). tive agent n= |
| PSS013904 | Actinic keratosis; via self-report | — | [ ,
44.0 % Male samples |
Mean = 57.04 years Sd = 7.88 years |
European | — | QSKIN | General-population (transplant-naive) |